FDA Wants Wockhardt Management Audited in Quality Data Probe

Drug Industry Daily
A A
The FDA is demanding Wockhardt investigate whether management was involved in quality data manipulation at its Chikalthana, India, facility before the agency will lift the import ban it has slapped on the plant.

To View This Article:

Login

Subscribe To Drug Industry Daily